Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2012 Dec;61(12):3081-3.
doi: 10.2337/db12-1157.

Ceramide and insulin resistance: how should the issue be approached?

Affiliations
Comment

Ceramide and insulin resistance: how should the issue be approached?

Jan Górski. Diabetes. 2012 Dec.
No abstract available

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
The pathways of ceramide metabolism examined in relation to insulin sensitivity. A: De novo synthesis. B: Deacylation. C: Phosphorylation of sphingosine (the work of Bruce et al. [15]). D: Hydrolysis of sphingomyelin. E: Conversion to glucosylceramide. F: Phosphorylation. De novo synthesis pathway is distinguished since it supplies all pathways of sphingolipid metabolism with ceramide.

Comment on

Similar articles

Cited by

References

    1. Lipina C, Hundal HS. Sphingolipids: agents provocateurs in the pathogenesis of insulin resistance. Diabetologia 2011;54:1596–1607 - PubMed
    1. Straczkowski M, Kowalska I. The role of skeletal muscle sphingolipids in the development of insulin resistance. Rev Diabet Stud 2008;5:13–24 - PMC - PubMed
    1. Summers SA. Sphingolipids and insulin resistance: the five Ws. Curr Opin Lipidol 2010;21:128–135 - PubMed
    1. Dobrzyń A, Górski J. Ceramides and sphingomyelins in skeletal muscles of the rat: content and composition. Effect of prolonged exercise. Am J Physiol Endocrinol Metab 2002;282:E277–E285 - PubMed
    1. Straczkowski M, Kowalska I, Nikolajuk A, et al. Relationship between insulin sensitivity and sphingomyelin signaling pathway in human skeletal muscle. Diabetes 2004;53:1215–1221 - PubMed

MeSH terms

Substances